Citi Stays Bearish on Moderna After Full Melanoma Vaccine Data
Citi remains bearish on Moderna following the release of full melanoma vaccine data. Moderna shares extended their slide.
Citi remains bearish on Moderna following the release of full melanoma vaccine data. Moderna shares extended their slide.